Equities

Utah Medical Products Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Utah Medical Products Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)67.06
  • Today's Change-0.03 / -0.04%
  • Shares traded4.10k
  • 1 Year change+13.22%
  • Beta0.3375
Data delayed at least 15 minutes, as of Mar 03 2026 15:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

  • Revenue in USD (TTM)38.63m
  • Net income in USD11.62m
  • Incorporated1978
  • Employees155.00
  • Location
    Utah Medical Products Inc7043 S 300 WestMIDVALE 84070United StatesUSA
  • Phone+1 (801) 521-5301
  • Fax+1 (801) 566-7305
  • Websitehttp://www.utahmed.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Accendra Health Inc4.72bn-123.85m179.63m6.50k----1.370.038-1.61-14.3061.33-6.031.3345.4130.05726,184.00-3.48-0.9299-5.75-1.4631.7025.69-2.62-0.7230.49991.081.29--3.06-20.1070.72--27.74--
InfuSystem Holdings Inc143.44m6.63m187.80m502.0029.463.289.411.310.31530.31536.812.841.4110.596.51--6.492.257.972.6955.9854.614.621.831.539.370.255--6.368.05182.60-17.49-12.48--
Lucid Diagnostics Inc4.40m-65.84m189.84m72.00------43.16-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
Rapid Micro Biosystems Inc30.52m-44.29m195.02m163.00--4.40--6.39-0.9984-0.99840.68841.000.32091.336.40187,257.70-46.56-38.13-56.14-43.367.72-27.98-145.11-253.022.95--0.3003--24.5711.1810.63---4.24--
Electromed Inc68.86m8.99m199.44m177.0023.464.3919.572.901.031.037.865.491.284.592.69389,045.2016.789.3320.1711.0478.2376.5613.068.404.49--0.000.0016.9714.5346.3512.62-20.72--
SANUWAVE Health Inc41.28m-7.04m206.34m46.00------5.00-0.9346-0.93464.68-0.34181.441.7511.07897,456.50-24.53-124.81----78.2671.67-17.06-144.710.8080.09991.14--59.9999.65-21.56--55.47--
Anika Therapeutics Inc82.20m13.91m206.51m288.0015.201.4110.212.510.9419-2.285.7010.180.39070.4863.25285,430.606.61-1.877.39-2.0654.2960.7416.92-4.734.47--0.00---0.73270.9077-156.70--24.14--
Stereotaxis Inc30.07m-24.91m207.18m139.00--32.27--6.89-0.281-0.2810.33930.12660.62321.474.54216,359.70-48.96-31.30-85.25-43.3153.0762.81-78.56-56.040.8108--0.00--0.5491-1.41-14.95--2.89--
OraSure Technologies Inc125.70m-60.24m212.33m501.00--0.5909--1.69-0.8107-0.81071.695.010.28342.074.91250,904.20-13.08-0.8506-14.16-0.959640.4144.80-46.15-1.396.20--0.0005---54.173.75-136.34---16.43--
Utah Medical Products Inc38.63m11.62m213.76m155.0018.981.8214.695.533.543.5411.7536.910.3071.9210.38249,245.209.2412.089.4812.5357.1060.8830.0831.0429.36--0.0037.43-18.56-2.70-16.60-0.8254-59.491.83
CVRx Inc56.65m-53.31m216.28m223.00--5.50--3.82-2.04-2.042.171.490.47560.68375.68254,040.40-44.76-39.12-49.79-42.1085.3382.74-94.10-130.776.72-8.800.5574--10.4556.4011.10--13.27--
KORU Medical Systems Inc39.07m-3.71m225.59m80.00--13.69--5.77-0.0807-0.08070.84820.35571.433.537.39488,383.00-13.62-19.85-18.41-23.1662.3259.62-9.50-24.861.92--0.0335--17.987.7555.85--25.82--
908 Devices Inc57.64m-57.10m239.24m246.00--1.75--4.15-1.61-0.11161.623.770.31231.764.17234,296.80-30.94-18.01-37.82-19.6749.3552.89-99.07-78.453.12--0.00--18.7227.11-98.37--8.96--
Simulations Plus Inc78.68m-64.25m244.38m212.00--1.92--3.11-3.20-3.203.906.310.4701--4.28371,113.20-38.39-2.50-40.84-2.6559.6069.96-81.66-7.29----0.00--13.0913.74-750.17--7.57-24.21
Applied Energetics Inc1.15m-13.02m244.68m21.00------212.19-0.0599-0.05990.0053-0.00330.3065--7.7054,908.57-345.27-139.08-454.84-208.3658.5860.61-1,126.59-473.16---------7.78---24.71--51.42--
Orchestra Biomed Holdings Inc2.82m-75.10m247.32m70.00--5.65--87.76-1.82-1.820.06760.77460.03130.657833.7540,257.14-83.39---104.85--93.01---2,665.05--4.72--0.2451---4.42---24.23------
Data as of Mar 03 2026. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD

Institutional shareholders

45.93%Per cent of shares held by top holders
HolderShares% Held
Brandes Investment Partners LPas of 31 Dec 2025351.32k10.97%
Renaissance Technologies LLCas of 31 Dec 2025193.61k6.04%
Dimensional Fund Advisors LPas of 31 Dec 2025187.88k5.86%
BlackRock Fund Advisorsas of 31 Dec 2025160.12k5.00%
The Vanguard Group, Inc.as of 31 Dec 2025155.68k4.86%
Hotchkis & Wiley Capital Management LLCas of 31 Dec 2025109.00k3.40%
Minerva Advisors LLCas of 31 Dec 202593.62k2.92%
Geode Capital Management LLCas of 31 Dec 202587.80k2.74%
SSgA Funds Management, Inc.as of 31 Dec 202568.01k2.12%
Rice, Hall, James & Associates LLCas of 31 Dec 202564.40k2.01%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.